Nirmatrelvir-ritonavir for outpatients with COVID-19. Case-based approach to assessment and treatment

被引:0
|
作者
LeBras, Marlys [1 ]
Crawley, Alex [2 ]
Legge, Marc [3 ]
Takaya, Satchan [4 ]
Lee, Stephen [5 ]
Regier, Loren [3 ]
机构
[1] Univ Saskatchewan, Programme Format Continue Pharmacotherapie, Saskatoon, SK, Canada
[2] Univ Saskatchewan, Programme Format Continue Pharmacotherapie RxFile, Saskatoon, SK, Canada
[3] Programme Format Continue Pharmacotherapie, Saskatoon, SK, Canada
[4] Univ Saskatchewan, Coll Med, Div Malad Infect, Saskatoon, SK, Canada
[5] Univ Saskatchewan, Coll Med, Malad Infect & Med Interne, Saskatoon, SK, Canada
关键词
D O I
10.46747/cfp.6908e170
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
[No abstract available]
引用
收藏
页码:E170 / E174
页数:5
相关论文
共 50 条
  • [31] Real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19
    Zeng, Guangting
    Wang, Linlin
    Li, Jianqiang
    Zhang, Zanling
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (06)
  • [32] Effectiveness of molnupiravir and nirmatrelvir-ritonavir in patients hospitalized with COVID-19: A target trial emulation study
    Yan, Vincent Ka Chun
    Wan, Eric Yuk Fai
    Mok, Anna Hoi Ying
    Chan, Esther Wai Yin
    Wong, Ian Chi Kei
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 264 - 264
  • [33] Effectiveness of Azvudine and Nirmatrelvir-ritonavir in Kidney Transplant Recipients With COVID-19: A Retrospective Cohort Study
    Liu, Y.
    Zhang, H.
    Liu, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [34] Nirmatrelvir-ritonavir compared with other antiviral drugs for the treatment of COVID-19 patients: A systematic review and meta-analysis
    Tian, Fangyuan
    Chen, Zhaoyan
    Feng, Qiyi
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (04)
  • [35] Predictors of nirmatrelvir-ritonavir receipt among COVID-19 patients in a large US health system
    Malden, Deborah E.
    Mclaughlin, John M.
    Hong, Vennis
    Lewnard, Joseph
    Ackerson, Bradley K.
    Puzniak, Laura
    Kim, Jeniffer S.
    Takhar, Harpreet
    Frankland, Timothy B.
    Slezak, Jeff M.
    Tartof, Sara Y.
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [36] In adults with postacute sequelae of COVID-19, nirmatrelvir-ritonavir did not improve symptoms at 10 wk
    Maki, Dennis G.
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (10) : JC118 - JC118
  • [37] Effectiveness of Nirmatrelvir-Ritonavir for the Prevention of COVID-19-Related Hospitalization and Mortality: A Systematic Literature Review
    Cha-Silva, Ashley S.
    Gavaghan, Meghan B.
    Bergroth, Tobias
    Alexander-Parrish, Ronika
    Yang, Jingyan
    Draica, Florin
    Patel, Jaymin
    Garner, Denise A.
    Stanford, Richard H.
    Meier, Genevieve
    Mclaughlin, John M.
    Nguyen, Jennifer L.
    AMERICAN JOURNAL OF THERAPEUTICS, 2024, 31 (03) : e246 - e257
  • [38] Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19 A Target Trial Emulation Study
    Wan, Eric Yuk Fai
    Yan, Vincent Ka Chun
    Mok, Anna Hoi Ying
    Wang, Boyuan
    Xu, Wanchun
    Cheng, Franco Wing Tak
    Lai, Francisco Tsz Tsun
    Chui, Celine Sze Ling
    Li, Xue
    Wong, Carlos King Ho
    Li, Philip Hei
    Cowling, Benjamin John
    Hung, Ivan Fan Ngai
    Lau, Chak Sing
    Wong, Ian Chi Kei
    Chan, Esther Wai Yin
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (04) : 505 - +
  • [39] Potential drug interaction after withdrawal of nirmatrelvir-ritonavir in hospitalized patients with COVID-19 infection
    Han, Yun
    Gou, Yonglan
    Liu, Jieqiong
    Yu, Lingyan
    Zhao, Yuhua
    Yu, Zhenwei
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2025, 42 : 151 - 153
  • [40] Nirmatrelvir plus ritonavir reduces COVID-19 hospitalization and prevents long COVID in adult outpatients
    Sharif-Askari, Fatemeh Saheb
    Alsayed, Hawra Ali Hussain
    Sharif-Askari, Narjes Saheb
    Hussain, Ali Al Sayed
    Al-Muhsen, Saleh
    Halwani, Rabih
    SCIENTIFIC REPORTS, 2024, 14 (01):